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ABSTRACT: The first total syntheses of sarcophytonolide H and the originally proposed and correct structures of 
isosarcophytonolide D have been achieved via transannular ring-closing metathesis (RCM). These total syntheses culminated in the 
stereostructural confirmation of sarcophytonolide H and the reassignment of isosarcophytonolide D, respectively. The antifouling 
activity of the synthetic sarcophytonolide H and its analogues was also evaluated. 
Corals have been recognized as a rich source of secondary 
metabolites with a variety of skeletons and biological 
activities.1 Cembranolide diterpenes,2 isolated from octocorals 
and soft corals, display a diverse range of biological activities 
such as antifouling,3 antifungal,4 antiviral,5 cytotoxic,6 and 
ichthyotoxic activities.7 Ecologically, it has been suggested 
that these natural products play significant roles in the survival 
of corals as defensive, competitive, and reproductive 
substances.1a,8 Sarcophytonolides are cembranolides isolated 
from the soft corals of genus Sarcophyton by Guo’s research 
group since 2005.9 As depicted in Figure 1, they have a 14-
membered macrocycle and a butenolide unit as common 
structures. We previously established the absolute 
configuration of (+)-sarcophytonolide C (1) by the total 
synthesis of its two possible stereoisomers at the C8 
position.10,11 The absolute stereochemistry of sarcophytonolide 
H (3), which possesses a β-oriented acetoxy group at the C14 
position, was determined by analysis of its 2D NMR spectra 
and the modified Mosher method.9b The relative configuration 
of sarcophytonolide D (2) bearing an α-positioned acetoxy 
moiety (C14) was elucidated by NOE observations.9a The 
relative stereochemistries at the C1, C2, and C14 positions of 
sarcophytonolides I (4), J (5), and isosarcophytonolide D (6) 
were determined by the similarity of their NMR data to those 
of sarcophytonolide D (2).9c,9d Qian and co-workers have 
reported that sarcophytonolides H (3) and J (5) show 
antifouling activity against the larval settlement of barnacle 
Balanus (Amphibalanus) amphitrite with EC50 values of 5.98 
μg/mL and 7.50 μg/mL, respectively.12 Herein, we describe 
the first total synthesis of sarcophytonolide H (3) and the 
originally proposed and correct structures of 
isosarcophytonolide D, which resulted in the stereostructural 
revision of isosarcophytonolide D. Furthermore, we also 
report the structure–antifouling activity relationship of 3. 
Figure 1. Structures of sarcophytonolides 1–6. 
Retrosynthetic analysis of sarcophytonolide H (3) and the 
proposed structure 6 of isosarcophytonolide D, wherein the 
structural differences are the oxidation degree at the C6 
position and the stereochemistry at the C14 position, is 
depicted in Scheme 1. The common structures, namely, the 
14-membered macrocycle and butenolide moiety, could 
potentially be constructed by macrolactonization13 and 
subsequent transannular ring-closing metathesis (RCM)14 of 
hydroxycarboxylic acids 7 and 8, respectively. 
Macrolactonization precursors 7 and 8 could possibly be 
prepared by the addition reaction of 2-alkoxycarbonyl allylic 
 metal 9 to aldehydes 10 and 11. The aldehydes 10 and 11 were 
broken down into allylic bromide 12 and aldehyde 13. 
Scheme 1. Retrosynthetic Analysis of Sarcophytonolide H 
(3) and the Proposed Structure 6 of Isosarcophytonolide D 
Our synthesis of the C14-stereoisomers 18 and 19 is 
described in Scheme 2. Selective acetylation of diol 1410 and 
subsequent protection of the remaining secondary hydroxy 
group with TBSOTf afforded the corresponding silyl ether. 
Reductive removal of the acetyl group with DIBAL-H 
followed by oxidation of alcohol 15 with TEMPO/PhI(OAc)215 
provided aldehyde 16. Treatment of 16 with allylic bromide 
1716 (1.2 equiv) in the presence of SmI217,18 produced the 
desired α-adducts 18 and 19 in 53% and 40% yields, 
respectively. Formation of the corresponding γ-adduct was not 
observed at all in this reaction.19 The C11/C12 alkene 
geometries of 18 and 19 were confirmed by the observed 
NOEs of H-11/H-13 (3% in 18 and 2% in 19). The resulting 
stereochemistry at the C14 position of 18 was determined by 
the modified Mosher method.20,21 
Scheme 2. Synthesis of Alcohols 18 and 19 
We next examined the transformation of 18 to sarcophy-
tonolide H (3) possessing the 14S configuration. Thus, protec-
tion of the secondary alcohol 18 as the MOM ether followed 
by selective removal of the primary TBS group gave alcohol 
20 (Scheme 3). TEMPO oxidation15 of 20 and subsequent 
Wittig reaction afforded alkene 21. The pivalate 21 was depro-
tected with DIBAL-H to yield alcohol 22, which was oxidized 
to the corresponding aldehyde. The asymmetric alkoxycar-
bonylallylation of the resulting aldehyde was carried out by 
using the chiral allylic boronate 23 according to Chataingner’s 
protocol22 to provide the desired product 24 in 88% yield over 
two steps with a 13:1 diastereoselectivity23. Protection of the 
resulting hydroxy moiety in 24 as the PMB ether, removal of 
the TBS protective group, and hydrolysis of the ester portion 
produced hydroxycarboxylic acid 25. Macrolactonization of 
25 was performed with 2-methyl-6-nitrobenzoic anhydride 
(MNBA)/DMAP24 to give the 15-membered lactone 26. The 
tetraene 26 was treated with second-generation Hoveyda–
Grubbs catalyst (27)25 to afford the desired product, whose 
C7/C8 and C11/C12 alkene portions were inert to the reaction 
conditions.26 The obtained butenolide underwent removal of 
the MOM group with HCl in i-PrOH27 to provide alcohol 28 in 
52% yield over two steps. The resulting hydroxy moiety in 28 
was acetylated and the PMB ether was deprotected with DDQ 
to produce sarcophytonolide H (3). The synthetic sarcophy-
tonolide H (3) displayed 1H and 13C NMR data21 and specific 
rotation28 which were in full agreement with those of the natu-
ral product.9b,29 Thus, the absolute configuration of 
sarcophytonolide H was unambiguously confirmed. 
Scheme 3. Synthesis of Sarcophytonolide H (3) 
 We next tried to synthesize the proposed structure 6 of 
isosarcophytonolide D with the 14R configuration. Thus, the 
alcohol 19 was transformed to 6 over 15 steps by the similar 
sequence to that used for sarcophytonolide H (3) (Scheme 4).21 
Scheme 4. Synthesis of the Proposed Structure 6 of 
Isosarcophytonolide D 
With the proposed structure 6 of isosarcophytonolide D in 
hand, we next carefully analyzed the 1H–1H COSY, HMQC, 
and HMBC spectra of 6 and compared the NMR data between 
the synthetic product 6 and the natural product. The 1H and 13C 
NMR data of the synthesized 6 were clearly different from the 
reported data of natural isosarcophytonolide D,9d 
respectively.21 Especially, as shown in Table 1, the chemical 
shift deviations were found to be critical around the C14 
position in both 1H and 13C NMR spectra. Therefore, we 
predicted the correct structure of isosarcophytonolide D to be 
that drawn as 37, which is the C14-epimer of 6 (Scheme 5). 
The ketone 37 was synthesized by treatment of the synthetic 
sarcophytonolide H (3) with Dess–Martin periodinane.30 As 
expected, the 1H and 13C NMR data of the synthetic product 37 
matched with those of natural isosarcophytonolide D.21 
Furthermore, the measured specific rotation of the synthesized 
37, [α]D24 = –50.9 (c = 0.07, CHCl3), was agreement with the 
data reported for the natural product, [α]D20 = –66 (c = 0.67, 
CHCl3).9d Therefore, the absolute stereochemistry of 
isosarcophytonolide D was revised to be that described in 37.31 
Table 1. Chemical Shift Deviations (ΔδN–S) between Natu-
ral Isosarcophytonolide D and the Synthetic 6 in the 1H 
and 13C NMRa 
position 1H NMR 13C NMR 
1 –0.24 +3.3 
2 –0.12 +0.9 
13 –0.24 –1.6 
 –0.02  
14 –0.37 +4.0 
15 –0.10 –2.6 
aδN and δS are chemical shifts of the natural product and the 
synthetic product. Chemical shifts are recorded in ppm with refer-
ence to the internal residual solvent signal (CDCl3, 7.26 ppm in 
1H NMR and 77.0 ppm in 13C NMR). 
Scheme 5. Synthesis of the Predicted Structure 37 of 
Isosarcophytonolide D 
We next evaluated the antifouling activity32 and toxicity of 
the synthetic sarcophytonolide H (3) and its analogues 38, 
39,33 25, and 22 against the cypris larvae of barnacle Balanus 
(Amphibalanus) amphitrite. Our results described in Table 2 
suggest that the tetraene 39, which was the most antifouling 
active and non-toxic, is a good candidate for further pursuing 
the environmentally-benign antifouling compound.21 
Table 2. Antifouling Activity (EC50) and Toxicity (LC50) of 
the Synthetic Sarcophytonolide H (3) and Its Analoguesa 
compound EC50 LC50 
3 3.36 >50 
38 3.08 >50 
39 1.61 >50 
25 3.27 19.4 
22 >50 >50 
aAgainst the cypris larvae of barnacle Balanus (Amphibalanus) 
amphitrite. EC50 and LC50 values in μg/mL. 
In conclusion, we have accomplished the first total synthesis 
of sarcophytonolide H (3) and the originally proposed and 
correct structures of isosarcophytonolide D, 6 and 37, by using 
 transannular RCM as a key step. The structural revision of 
isosarcophytonolide D suggests that the C14 stereochemistries 
of sarcophytonolides D (2), I (4), and J (5) also need to be 
reconsidered. We also evaluated the antifouling activity and 
the toxicity of the synthetic sarcophytonolide H and its 
analogues, which denotes that the tetraene 39 is a good candi-
date for the creation of the antifouling agent without toxicity. 
Further synthetic and biological study of sarcophytonolides is 
currently underway. 
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